Sex- and age-dependent energetic dysfunction in LRRK2 G2019S Parkinson’s model revealed by structural analysis of RGC dendritic architecture and metabolic profiling of optic nerve

Parkinson's disease is a condition that slowly wears away the brain's ability to control movement, affecting millions of people worldwide. While doctors typically wait for tremors or stiffness to appear before making a diagnosis, the damage often begins much earlier, silently altering cells long before symptoms emerge. One of the first places this damage can be spotted is in the retina, the light-sensitive layer at the back of the eye. The retina is not just a window for vision; it is a direct extension of the brain, sharing many of the same cells and vulnerabilities. Because these cells, known as retinal ganglion cells, work constantly to send electrical signals, they require a tremendous amount of energy to keep functioning. If the body's ability to produce or manage that energy falters, these cells are among the first to struggle, making the eye a sensitive early warning system for neurological trouble.

A new study has looked closely at how this energy failure unfolds in a specific genetic form of Parkinson's disease, revealing that the timing and nature of the breakdown depend heavily on whether the patient is male or female. Researchers examined mice carrying a specific genetic mutation known to cause Parkinson's in humans, tracking them at three distinct stages of life: four weeks, eight weeks, and seventy-two weeks. By mapping the intricate branching patterns of the nerve cells in the retina and analyzing the chemical fuel available in the optic nerve, the team discovered that the disease does not follow a single, uniform path. Instead, it takes two very different roads depending on sex, with males showing signs of trouble much earlier than females, even though both groups eventually arrive at a similar state of decline.

The investigation began by looking at the physical structure of the nerve cells. In the healthy brain, these cells spread out their branches like a complex tree to connect with other cells. In the male mice carrying the mutation, this branching pattern began to shrink and simplify as early as four weeks of age, indicating that the cells were already struggling to maintain their structure. In contrast, the female mice with the same mutation showed no such structural damage at four weeks; their nerve cells looked just as complex and healthy as those in mice without the mutation. It was not until eight weeks that the female mice began to show similar signs of structural decline. By the time the animals reached seventy-two weeks, the differences between the sexes had faded, and both groups showed a loss of complexity, suggesting that while the starting points and speeds were different, the long-term outcome was the same.

To understand why the males faltered so much sooner, the researchers turned to the chemistry of the optic nerve, looking for clues in the small molecules that cells use to generate energy. They found that the metabolic profiles of the two sexes were fundamentally different from the start. In the young male mice, the mutation caused a drop in the availability of key energy-building blocks, specifically those related to purines and riboflavin, which are essential for cellular power plants to function. This lack of fuel appeared to coincide directly with the early structural damage seen in their nerve cells. The female mice, however, displayed a different chemical story. At four weeks, their bodies seemed to ramp up production of various energy-related compounds, including those involved in antioxidant defense and nucleotide synthesis. This surge suggested that the female mice were mounting an early, adaptive response to the genetic stress, temporarily holding off the damage that would later appear.

As the animals aged, these distinct metabolic paths began to shift. The female mice, which had initially held the advantage, saw their protective chemical surge fade by eight weeks, and their nerve cells began to show the same structural decline as the males. The researchers observed that the metabolic trajectories of the two sexes, which started out so different, eventually converged as the animals grew older. By seventy-two weeks, both males and females with the mutation showed signs of impaired energy production, including a reduced ability to process fatty acids and a decline in the efficiency of their cellular energy cycles. The early metabolic resilience that allowed the females to delay the onset of damage did not prevent it forever; it simply bought them more time before the system began to fail.

The study highlights that the biological sex of an individual is a critical factor in how Parkinson's disease develops, influencing not just the speed of progression but the specific molecular mechanisms at play. The findings suggest that the mutation disrupts the normal maturation of cellular energy systems in a way that is unique to each sex. While males experience an early failure in energy production that leads to rapid structural decline, females initially compensate with a heightened metabolic response that delays the damage but does not stop it. This difference in timing and mechanism implies that a single treatment approach might not work for everyone. Understanding these distinct pathways could help scientists design interventions that target the specific metabolic weaknesses of each sex, potentially preserving nerve health for longer during the critical early stages of the disease.